Rare
lephants
Screener
Toggle theme
Charles River Laboratories International Inc.
CRL
·
Healthcare, Diagnostics & Research, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations:
$168.2M
Line Item
Value
% of Total
Capital Expenditures
$18.1M
10.7%
Stock Repurchases
$150.2M
89.3%
Net Cash Flow
$0
0.0%
Download CSV
